Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Esperion Therapeutics Inc. shares valued at $227 were sold by Warren Eric on Oct 17 ’24. At $2.12 per share, Warren Eric sold 107 shares. The insider’s holdings dropped to 162,552 shares worth approximately $0.33 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Warren Eric purchased 107 shares, netting a total of over 227 in proceeds.
Before that, Koenig Sheldon L. had sold 14,550 shares from its account. In a trade valued at $26,132, the President and CEO traded Esperion Therapeutics Inc. shares for $1.80 each. Upon closing the transaction, the insider’s holdings decreased to 14,550 shares, worth approximately $1.55 million.
As published in a research note from BofA Securities on June 20, 2024, Esperion Therapeutics Inc. [ESPR] has been rated down from a Neutral to an Underperform and the price target has been revised to $2.50. Analysts at BofA Securities downgraded the stock from ‘”a Buy”‘ to ‘”a Neutral”‘ outlook in a report released in early January. Earlier on August 01, 2023, Northland Capital upgraded its rating. Their new recommendation was “a Market perform” for ESPR stock which previously was a “an Under perform”.
Analyzing ESPR Stock Performance
During the last five days, there has been a drop of approximately -2.37%. Over the course of the year, Esperion Therapeutics Inc. shares have dropped approximately -31.10%. Shares of the company reached a 52-week high of $3.40 on 04/08/24 and a 52-week low of $1.58 on 10/02/24. A 50-day SMA is recorded $1.85, while a 200-day SMA reached $2.23. Nevertheless, trading volume fell to 1.76 million shares from 2.84 million shares the previous day.
Support And Resistance Levels for Esperion Therapeutics Inc. (ESPR)
According to the 24-hour chart, there is a support level at 2.02, which, if violated, would cause prices to drop to 1.99. In the upper region, resistance lies at 2.11. The next price resistance is at 2.15. RSI (Relative Strength Index) is 55.91 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.03, which suggests the price will decrease in the coming days. Percent R is at 38.46%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
